𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prevention of onset of Parkinson’s disease by in vivo gene transfer of human hepatocyte growth factor in rodent model: a model of gene therapy for Parkinson’s disease

✍ Scribed by Koike, H; Ishida, A; Shimamura, M; Mizuno, S; Nakamura, T; Ogihara, T; Kaneda, Y; Morishita, R

Book ID
110039860
Publisher
Nature Publishing Group
Year
2006
Tongue
English
Weight
244 KB
Volume
13
Category
Article
ISSN
0969-7128

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Data protection in biomaterial banks for
Data protection in biomaterial banks for Parkinson's disease research: The model of GEPARD (Gene bank Parkinson's Disease Germany)
✍ Karla Eggert; Ullrich Wüllner; Gisela Antony; Thomas Gasser; Bernd Janetzky; Chr 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

## Abstract Parkinson's disease (PD) is the second most common neurodegenerative disease. Although 10 gene loci have been identified to cause a Parkinsonian syndrome, these loci account only for a minority of PD patients. Large, systematic research programs are required to collect, store, and analy

In vivo gene delivery of glial cell line
In vivo gene delivery of glial cell line–derived neurotrophic factor for Parkinson's disease
✍ Jeffrey H. Kordower 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 564 KB

Parkinson's disease (PD) is a progressive neurodegenerative disorder that affects approximately 1,000,000 Americans. The cause of the disease remains unknown. The histopathological hallmarks of the disease are dopaminergic striatal insufficiency secondary to a loss of dopaminergic neurons in the sub

Hexokinase II gene transfer protects aga
Hexokinase II gene transfer protects against neurodegeneration in the rotenone and MPTP mouse models of Parkinson's disease
✍ Juan Carlos Corona; Alfredo Gimenez-Cassina; Filip Lim; Javier Díaz-Nido 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 407 KB

## Abstract A typical feature of Parkinson's disease is the progressive loss of dopaminergic neurons in the substantia nigra, in which inhibition of mitochondrial complex I activity may play an important role. Rotenone or 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) inhibit the mitochondrial